Edwards Lifesciences (EW) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Edwards Lifesciences, as the data feed reports them.

Analysts' mean target, 27 analysts
$113.39
6.6% above the price

The 27 analysts reported by the data feed have a mean price target for Edwards Lifesciences of $113.39, 6.6% above the $106.33 price (range $84.00–$126.00). 1.86% of the float was sold short as of Oct 30, 2026. Institutions hold 94.4% of the shares and insiders 0.4%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$113.39+6.6% vs price
Analysts
27
Short interest
1.86%of float, Oct 30, 2026
Short ratio
2.58 days
Institutions
94.4%
Insiders
0.40%
Beta
0.83

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

27 analysts covering Edwards Lifesciences, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $106.33.

Analysts' price targets for Edwards Lifesciences
Mean price target$113.396.6% above the price (+6.6%)
Median price target$115.008.2% above the price (+8.2%)
Highest target$126.0018.5% above the price (+18.5%)
Lowest target$84.0021.0% below the price (−21.0%)
Analysts with a target27

Ratings this month · 30 analysts

Strong buy 5(17%)Buy 20(67%)Hold 4(13%)Strong sell 1(3%)
Analysts' ratings of Edwards Lifesciences this month, by rating
RatingAnalystsShare
Strong buy517%
Buy2067%
Hold413%
Sell00%
Strong sell13%

The feed averages these to 1.53 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “buy”.

Who owns Edwards Lifesciences

Ownership of Edwards Lifesciences
Held by institutions94.4%1,955 institutions; percent of shares outstanding
Held by institutions, of the float94.8%
Held by insiders0.40%percent of shares outstanding
Shares outstanding575M
Float573.22Mshares available to trade
Insiders' net purchases, six months+49.04K13 purchases (218K shares), 21 sales (168.96K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Edwards Lifesciences
Shares short9.38Mas of Oct 30, 2026
Percent of float1.86%shares short ÷ float
Percent of shares outstanding1.63%shares short ÷ shares outstanding
Short ratio (days to cover)2.58shares short ÷ average daily volume

Edwards Lifesciences short interest from FINRA, with its history

Trading figures

Trading figures for Edwards Lifesciences
Beta0.83movement against the market; 1 moves with it
52-week high$108.00
52-week low$74.66
Average volume, 3 months3.86Mshares a day
Average volume, 10 days5.6Mshares a day

Questions and answers

What is the analysts' price target for Edwards Lifesciences (EW)?

As reported by the data feed, the mean price target of the 27 analysts covering Edwards Lifesciences is $113.39, 6.6% above the latest price of $106.33. The highest target is $126.00 and the lowest $84.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Edwards Lifesciences stock?

Of the 30 ratings the data feed reports for the current month, 5 are strong buy, 20 buy, 4 hold, 0 sell and 1 strong sell.

How many Edwards Lifesciences shares are sold short?

As reported by the data feed, 9.38M shares were sold short, 1.86% of the float as of Oct 30, 2026. At the average daily volume that is 2.58 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Edwards Lifesciences stock?

As reported by the data feed, institutions hold 94.4% of the shares (1,955 institutions) and insiders 0.4%. There are 575M shares outstanding, of which 573.22M are in the float.

How much does Edwards Lifesciences stock move with the market?

Its beta, as reported by the data feed, is 0.83: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $74.66 and $108.00.

Cite this page

Funkfolio, “Edwards Lifesciences (EW) statistics and analyst targets”, data as of 17 November 2026. https://funkfolio.com/stock/EW/statistics

Underlying data: Yahoo Finance.